Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
| Product: | FLUCELVAX QUAD |
| Active Ingredient: | Influenza vaccine, inactivated, split virion 60mcg |
| Dosage Form: | Suspension for injection |
| New Zealand Sponsor: | Seqirus (NZ) Limited |
| Manufacturers: | CSL Behring GmbH, Marburg, Germany Seqirus Inc., North Carolina, United States of America |
Dated this 28th day of July 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).